MacDougall Senior VP, IR, @MichelmoreSara will be moderating @IAmBiotech’s BIO Investor Forum Digital panel, “Market Outlook: Solid Ground or Thin Ice?” on Wednesday, October 14 from 2:00pm – 2:55pm PDT: https://t.co/XwnUiFtnyf
#BIODigital attendees: ICYMI: watch our panel, 'N of Few' - Clinical Trial Design for Small Cohorts, hosted by @BioWorld's @mfitz w panelists @LaurieAHalloran of @HalloranConsult Brad Glasscock of BioMarin and @Sudhir_Arnay of ARNAY Sciences. https://t.co/tX6mcrj7vv @IAmBiotech
MacDougall joins our neighbors, colleagues, scientists, families and friends in supporting those fighting racism and inequity. As part of our commitment to impactful change in our communities and workplaces, we’ve donated to the @NAACP_LDF and @LS_Cares.
Another MacDougall Breakout Session JPM Fun Run is in the books. Thanks to everyone who hit the streets of #SanFrancisco with us this morning and started our #JPM20 week off on the right foot! #JPM2020#biotechshowcase
Interesting tidbit from Evercore ISI biotech analysts Josh Schimmer & Ravi Mehrotra, credited to Biotech OG Stelios Papadopoulous - October marks the 40th anniversary of the #biotechIPO! Can you name the company?
It's finally happening - look for big changes to the Corporate Access game in 2020: A series of meetings set up by investing firms with corporate executives is a direct threat to the millions of dollars in fees banks make each year. https://t.co/Qgpd2UNV4t via @WSJ
Our managing partner, @macbiokari, will participate in the @BusinessWire webinar “Best Practices for Biotech Communications Professionals” tomorrow at 2 PM ET. Register to learn the latest #SciComm strategies. https://t.co/EoUFsdhZjf #biotech
Congratulations to our client @Promethera on closing their largest financing round to date to push #celltherapy in severe liver diseases such as #NASH and #ACLF
Great article on the need for better #donor organ preservation technology, highlighting the work and commitment of our client @ParagonixSherpa to change the status quo with #Sherpapak
@ParagonixSherpa is changing the standard of how #donor organs are preserved as they travel to recipient by removing the risk of cold injury. Read more at https://t.co/VwlLG1mJo5 via @BosBizJournal#SherpaPak
Preservation and respect - what's missing in the current way that organs are transported and the reason #SherpaPak CTS was created; so proud to work with Lisa Anderson and @ParagonixSherpa#client
Merci @FACCNE for the opportunity to speak about Life Science #IPO best practices! Also enjoyed hearing @sbancel discuss the evolution of @moderna_tx and left feeling hopeful about the potential for mRNA Tx to bring much needed treatments to patients globally.
Expecting 180 attendees tonight at the 7th Annual #lifesciences Panorama @IpsenGroup in @kendall_square!! We can still accept a few online registrations: https://t.co/E6TfTGu2bz and accommodate some walk-ins. See you at 6pm!
https://t.co/ST8R72fHK1